Cited by 47Diabetes, Cardiovascular Risks, and LipoproteinsHealth Promotion and Cardiovascular PreventionDiabetes Management and Research

Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross‐sectional population‐based study

Hellgren, M. I., Petzold, M., Björkelund, C., Wedel, H., Jansson, P.‐A., Lindblad, U.·2012·Diabetic Medicine

Abstract

Aim To evaluate the performance of the FINDRISC questionnaire as a tool to recruit individuals with impaired glucose tolerance for lifestyle intervention programmes. Methods A cross-sectional population-based study in primary Health Care Centres in a middle-sized Swedish town. All 9734 individuals, aged 35-75 years, living within a defined area, were invited by mail to fill in and return the FINDRISC questionnaire. Participants with a risk score ≥ 15 (n = 525) were invited to perform an oral glucose tolerance test while those with known diabetes were excluded. Results In total, 5452 questionnaires (58%) were returned and revealed a mean risk-score of 8.5 ± 4.5 (mean ± SD). We found that 525 participants had a risk-score ≥ 15 and 302 (58%) were further examined with an oral glucose tolerance testing (OGTT). Among them we detected 11% with previously undiagnosed Type 2 diabetes, 16% with impaired glucose tolerance and 29% with impaired fasting glucose. A FINDRISC score ≥ 15 was associated with a positive predictive value of 55% for impaired glucose metabolism (impaired fasting glucose + impaired glucose tolerance + Type 2 diabetes) and of 16% for impaired glucose tolerance, respectively. The positive predictive value for impaired glucose tolerance did not increase to more than 17% when choosing the cut-point 17, while there was a significant increase in the positive predictive value for impaired glucose metabolism (70%). Conclusions The FINDRISC questionnaire is a useful instru…

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2012.03664.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • FINDRISC is the most commonly evaluated diabetes risk score worldwide and has been recommended as the best available risk assessment tool for clinical practice by a systematic review.

    “Moreover, FINDRISC is the most commonly evaluated diabetes risk score worldwide [17,18,19,20,21,22,23,24,25] and has been recommended as the best available risk assessment tool for use in the clinical practice by a systematic review [11].”

Cites

Flagged first, then by citations

Authors
Hellgren, M. I., Petzold, M., Björkelund, C., Wedel, H., Jansson, P. ‐., & Lindblad, U.
Affiliations
  • University of Gothenburg (SE)
  • Nordic School of Public Health (SE)
Corresponding author
Hellgren, M. I.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2012-11-14
Volume
29
Issue
12
Pages
1501-1505
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1574782806
Cited by
47
References
3
Citations by year
2025: 2 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 6 · 2017: 4 · 2016: 9 · 2015: 3 · 2014: 6 · 2013: 2 · 2012: 1
FWCI
3.07
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetic Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Göteborgs Universitet
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
FINDRISC questionnaire, impaired glucose tolerance, impaired fasting glucose, type 2 diabetes, risk score, screening, positive predictive value, oral glucose tolerance test, primary care, undiagnosed diabetes
MeSH terms
Adult, Aged, Antihypertensive Agents, Blood Glucose, Community Health Services, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Fasting, Feasibility Studies, Female, Fruit, Glucose Tolerance Test, Humans, Male, Middle Aged, Patient Compliance, Predictive Value of Tests, Primary Health Care, Surveys and Questionnaires, Risk Factors, Sweden, Vegetables, Exercise, Body Mass Index, Glucose Intolerance, Patient Selection, Waist Circumference

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review